Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis. - Test2 - elhamkhani - TriplyDB

Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.

Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.

http://www.wikidata.org/entity/Q40483712

about

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies.Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).Clinical Development of PD-1 Blockade in Hematologic Malignancies.Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.PD-L1 Expression and CD8+ T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer.Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis

P2860

Q33638083-5D4D951E-C920-47A7-9E90-AB90599BA25C Q33833832-7C7FDA42-F24F-4C6E-AE24-298212C79708 Q39284101-FC35278C-F3DB-425D-BB18-7FA99F934E59 Q48526801-B5B97BCA-E672-411F-BA28-866875E3BD95 Q55262931-F0BA5C1B-2F4A-4D88-B86C-D1FD642DE222 Q55554951-DC315193-AD09-4431-B5CA-F9DF8D1222DF Q58723337-F495C5B5-6E9A-44A4-91ED-2C9C502CF82F Q58742961-9B79820E-3EC8-4545-ABCE-7F500379F454 Q58804963-C209D101-56B5-4C60-A03F-EFCA0B070660

P2860

Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.

http://www.wikidata.org/entity/Q40483712

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Expression of programmed cell ...... ociated with better prognosis.

@en

type

label

Expression of programmed cell ...... ociated with better prognosis.

@en

prefLabel

Expression of programmed cell ...... ociated with better prognosis.

@en

P1433

Q40483712-8C5C05DE-3BE9-4B75-8780-C1D50B247788

P1476

Q40483712-78B4C152-26CD-46FB-8035-0439D568BF26

P2093

Q40483712-036A93F8-C926-4E63-829E-A4455BBE812C

Q40483712-0F4818FE-3257-4B99-9082-7F4190249B0F

Q40483712-4D176767-A4A8-4729-8753-0D70D6A287D6

Q40483712-6B26EFCC-26A5-444B-934D-AE9BE58AEEDD

Q40483712-AB3DE082-9C0F-4985-B554-9DFA2D5C7D00

Q40483712-F0FE1C12-C790-4B25-91E5-24129A1BC271

P2860

Q40483712-131E55B6-52CE-4C17-B174-12BD8AEB462C

Q40483712-25D2BCCA-2531-4B18-8BD5-6162BA5EA042

Q40483712-2C6F55FD-70C7-43CD-B06D-98E8720B956C

Q40483712-377C2506-1EDF-4D9F-8996-C71CAC775F1D

Q40483712-4444058B-9111-431B-B55C-700C7570AC17

Q40483712-448CCD6D-36EA-4570-8F31-4C73D4159F1D

Q40483712-57390A43-80F6-4C59-93B3-7B0AC65CC9EE

Q40483712-59AF4A93-43D0-4FF5-8108-E1B9DFE1CC59

Q40483712-59B1E65A-6DE8-40DB-8E00-832F43B3C34A

Q40483712-5AC5B155-B827-41C1-8252-099668550B48

P2888

Q40483712-BE6AFFF8-6713-4141-8BB7-E6CB2DDEDABA

P304

Q40483712-BC5A7438-75FB-4435-A048-35709233ECDB

P31

Q40483712-8955983E-92D1-42E0-BD1A-1147603B6223

P356

Q40483712-6BB565BB-5C8B-4AEA-9578-EB8C8EDF69B8

P433

Q40483712-D1BA49E0-6361-4833-82EB-61C74332CFCF

P478

Q40483712-D5057464-6F1C-4295-AC0E-14F94A7D017D

P50

Q40483712-D542F173-38AC-44A1-8547-51E65F3AE559

P577

Q40483712-18034E34-C566-49DC-AD32-A7AD2FB7DBF2

P6179

Q40483712-89039EF6-1AA4-47E2-9A7A-AB64638A61E8

P698

Q40483712-A30D6257-65DE-40CA-9B4F-51B89F962041

P356

S00428-016-2011-0

P1433

Virchows Archiv

P1476

Expression of programmed cell ...... ociated with better prognosis.

@en

P2093

Chul-Woo Kim

http://www.w3.org/2001/XMLSchema#string

Dae Seog Heo

http://www.w3.org/2001/XMLSchema#string

Ho Young Jung

http://www.w3.org/2001/XMLSchema#string

Soo Jeong Nam

http://www.w3.org/2001/XMLSchema#string

Tae Min Kim

http://www.w3.org/2001/XMLSchema#string

Yoon Kyung Jeon

http://www.w3.org/2001/XMLSchema#string

P2860

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

PD-1 and its ligands in tolerance and immunity

Restoring function in exhausted CD8 T cells during chronic viral infection

Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Epstein-Barr virus infection.

P2888

s00428-016-2011-0

P304

581-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-016-2011-0

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

469

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015032403

http://www.w3.org/2001/XMLSchema#string

P698

27595782

http://www.w3.org/2001/XMLSchema#string